Impact on human intestinal microflora of an Enterococcus faecium probiotic and vancomycin

Scandinavian Journal of Infectious Diseases

Volumn 32, Issue 6, 2000, Pages 627-632

  Lund, B ^a   Edlund, C ^a   Barkholt, L ^a   Nord, C E ^a   Tvede, M ^a   Poulsen, R L ^a  

^a KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

AVOPARCIN; GLYCOPEPTIDE; PROBIOTIC AGENT; VANCOMYCIN;

ADULT; ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIAL COUNT; BACTERIUM CARRIER; CLINICAL TRIAL; COLONY FORMING UNIT; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DENMARK; DIET SUPPLEMENTATION; ENTEROCOCCUS FAECIUM; FECES ANALYSIS; FEMALE; FERMENTED PRODUCT; FOOD INTAKE; HUMAN; HUMAN EXPERIMENT; INTESTINE FLORA; MALE; MILK; NORMAL HUMAN; RANDOMIZED CONTROLLED TRIAL; RISK; SINGLE BLIND PROCEDURE; SWEDEN; VOLUNTEER;

ADULT; ANTI-BACTERIAL AGENTS; DAIRY PRODUCTS; DRUG RESISTANCE, BACTERIAL; ENTEROCOCCUS FAECIUM; FECES; FEMALE; FERMENTATION; HUMANS; INTESTINES; MALE; MICROBIAL SENSITIVITY TESTS; PROBIOTICS; PROSPECTIVE STUDIES; RISK FACTORS; TIME FACTORS; VANCOMYCIN; VANCOMYCIN RESISTANCE;

EID: 0034525626     PISSN: 00365548     EISSN: None     Source Type: Journal    
DOI: 10.1080/003655400459531     Document Type: Article

References (21)

1. Effect of Lactobacillus GG yoghurt in prevention of antibiotic associated diarrhea
2. Oral supplementation with lactic acid-producing bacteria during intake of clindamycin
3. Effect of supplements with lactic acid bacteria and oligofructose on the intestinal microflora during administration of cefpodoxime proxetil
4. Hypocholesterolaemic effect of a new fermented milk product in healthy middle-aged men
5. The coming age of probiotics
6. Vancomycin-resistant enterococci: The clinical effect of a common nosocomial pathogen
7. Current perspectives on multidrug-resistant bacteria
8. First documented isolation of vancomycin-resistant Enterococcus faecium in Sweden
9. Intrahospital spread of vancomycin-resistant Enterococcus faecium in Sweden
10. Near absence of vancomycin-resistant enterococci but high carriage rates of quinolone-resistant ampicillin-resistant enterococci among hospitalized patients and nonhospitalized individuals in Sweden
11. Glycopeptide susceptibility among Danish Enterococcus faecium and Enterococcus faecalis isolates of animal and human origin and PCR identification of genes within the VanA cluster
12. Detection of clinical vancomycin-resistant enterococci in Denmark by multiplex PCR and sandwich hybridization
13. Comparative effects of moxifloxacin and clarithromycin on the normal intestinal microflora
14. Lactobacillus endocarditis caused by a probiotic organism
15. Saccharomyces boulardii fungemia in a patient receiving Ultra-levure therapy
16. Impact of Lactobacillus acidophilus supplements on the human oropharyngeal and intestinal microflora
17. Effect of administration of Lactobacillus casei strains GG on the intestinal microbiota of newborns
18. Effect of vancomycin on intestinal flora of patients who previously received antimicrobial therapy
19. Historical yearly usage of glycopeptides for animals and humans: The American-European paradox revisited
20. Vancomycin-resistant enterococci in turkeys and farmers
21. Vancomycin-resistant Enterococcus faecium strains with highly similar pulsed-field gel electrophoresis patterns containing similar Tn1546-like elements isolated from a hospitalized patient and pigs in Denmark